Cytokinetics | CYTK - Selling And Administration Expenses


Cytokinetics reported $104.4M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Acadia Pharmaceuticals USD 148.57M 12.22M Jun/2026
Amgen USD 1.72B 134M Jun/2026
Arca Biopharma USD 2.23M 1.08M Dec/2025
Bayer EUR 3.96B 267M Jun/2026
Biogen USD 709.7M 155.4M Jun/2026
Brainstorm Cell Therapeutics USD 1.21M 178K Mar/2026
Bristol-Myers Squibb USD 1.83B 209M Jun/2026
Capricor Therapeutics USD 1.92M 446.47K Dec/2025
Cytokinetics USD 104.4M 499K Jun/2026
Eisai JPY 114.83B 4.71B Jun/2026
Eli Lilly USD 3.43B 496M Jun/2026
Exelixis USD 147.63M 8.03M Jun/2026
Geron USD 35.42M 6.24M Mar/2026
Halozyme Therapeutics USD 57M 10.71M Jun/2026
Ionis Pharmaceuticals USD 130.07M 20.92M Jun/2026
Ligand Pharmaceuticals USD 29.12M 8.29M Jun/2026
Merck USD 2.89B 219M Jun/2026
Novartis USD 3.24B 101M Jun/2026
Pfizer USD 3.41B 496M Jun/2026
Regeneron Pharmaceuticals USD 662.1M 14.4M Jun/2026
Roche Holding CHF 6.37B 908M Jun/2026
Sanofi EUR 2.63B 307M Jun/2026